FDA Adverse Event
Malfunction
Summary report: N
NUEROMOD LENIRE
MDR report key: 18494670
·
Received January 10, 2024
Report
- Report Number
- MW5150147
- Event Type
- Malfunction
- Date Received
- January 10, 2024
- Date of Event
- November 15, 2023
- Report Date
- January 8, 2024
- Manufacturer
- NUEROMOD / NEUROMOD DEVICES LIMITED
- Product Code
- QVN
- Product Problem
- Yes
- Report Source
- Voluntary report
- Reporter Location
- UT, US
- Reporter Occupation
- PATIENT
- Health Professional
- *
Narratives
Description of Event or Problem · 0
THE LENIRE DEVICE FOR TINNITUS RECEIVED DE NOVO APPROVAL LAST YEAR. THIS LED ME TO SPEND OVER (B)(6) GETTING THE DEVICE. IT SEEMED TO CAUSE RATHER SEVERE BRAIN FOG IN ME THAT LASTED A FEW WEEKS AFTER STOPPING USE OF THE DEVICE. THE DEVICE FAILED IN ANY WAY TO IMPROVE MY TINNITUS ONCE THE BRAIN FOG CLEARED UP. IT CAME ACROSS AS A BIG SCAM TO ME. HOPEFULLY, OTHERS WILL HAVE BETTER RESULTS, BUT I BELIEVE IT BEARS WATCHING. (B)(6).
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1677139 | NUEROMOD LENIRE | COMBINED ACOUSTIC AND ELECTRICAL EXTERNAL STIMULATION DEVICE FOR THE RELIEF OF T | QVN | NUEROMOD / NEUROMOD DEVICES LIMITED |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 72 YR | Male | ATORVASTATIN.| CALCIUM SUPPLEMENT.| CLOPIDOGREL.| HYDROCHLOROTHIAZUDE.| LEVOTHYROXINE.| MVI .| OLMESARTAN.| RESTORIL.| TOPICAL MINOXIDIL.| VITAMIN C. |